Can we predict development of bronchiolitis obliterans syndrome (BOS) according to parameters of oxidative stress in lung transplant recipients? Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007
Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011
The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx) Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation Year: 2007
Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Lung clearance index (LCI) as a sensitive marker of post-transplant bronchiolitis obliterans syndrome (BOS) Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions Year: 2018
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004
Effects of posttransplant bronchiolitis obliterans syndrome (BOS) on exhaled nitric oxide (eNO) Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment Year: 2003
Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome Source: Eur Respir J 2005; 25: 813-819 Year: 2005
Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet? Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55 Year: 2004
Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004
Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Source: Eur Respir J 2005; 25: 221-224 Year: 2005
Pulmonary distribution of oxygen partial pressure in lung transplant recipients: assessment by oxygen-sensitive 3 He-MRI to indicate bronchiolitis obliterans (BO) Source: Eur Respir J 2005; 26: Suppl. 49, 176s Year: 2005
Pulmonary function and clinical outcome of patients with post-infectious bronchiolitis obliterans (BO) Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19 Year: 2004
Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004
Acinar ventilation heterogeneity (Sacin) assessed by nitrogen multiple breath washout is an accurate and sensitive marker of bronchiolitis obliterans (BO) Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014
Introduction: new therapeutic approaches to bronchiolitis obliterans Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005
Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008
Post-transplant bronchiolitis obliterans Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=158 Year: 2003